Name (Synonyms) | Correlation | |
---|---|---|
drug1041 | vv-ECMO + cytokine adsorption (Cytosorb adsorber) Wiki | 1.00 |
drug1042 | vv-ECMO only (no cytokine adsorption) Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D011014 | Pneumonia NIH | 0.08 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.07 |
D018352 | Coronavirus Infections NIH | 0.06 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
All patients included in this search will be on anonymized file: Symptomatic patients consulting for suspicion of COVID 19 with indication to a screening (RT-PCR, Scanner) according to the criteria of the Ministry of Health. To evaluate the diagnostic performance of chest CT in screening for COVID-related lung injury in patients with a clinical suspicion of COVID. CT scan results for COVID according to French thoracic imaging society will be dichotomized into evocative or compatible (considered positive) non-evocative (considered negative) The results will be compared to the gold standard corresponding to a multiparametric element: the discharge summary. Ct Scan performance will be recorded and analyzed.
Description: CT Report will dichotomized into evocative or non-evocative for COVID-related lung injury.
Measure: Diagnostic performance of chest CT in screening for pulmonary lesions in clinical suspicions of COVID. Time: 1 monthDescription: Initial virological RT-PCR results: positive or negative depending on the laboratories of the institutions. Scanner results according to French Thoracic Imaging Society.
Measure: Compare the diagnostic performance of chest CT and RT-PCR in COVID 19 at the initial consultation (screening). Time: 1 month